|
1
|
Dutta DK and Dutta I: Origin of ovarian
cancer: Molecular profiling. J Obstet Gynaecol India. 63:152–157.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spaderna S, Schmalhofer O, Wahlbuhl M,
Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A,
et al: The transcriptional repressor ZEB1 promotes metastasis and
loss of cell polarity in cancer. Cancer Res. 68:537–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aigner K, Dampier B, Descovich L, Mikula
M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist
P, et al: The transcription factor ZEB1 (deltaEF1) promotes tumour
cell dedifferentiation by repressing master regulators of
epithelial polarity. Oncogene. 26:6979–6988. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang P, Sun Y and Ma L: ZEB1: At the
crossroads of epithelial-mesenchymal transition, metastasis and
therapy resistance. Cell Cycle. 14:481–487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng G, Wang X, Cao X, Shen L and Zhu J:
ZEB1 expression in endometrial biopsy predicts lymph node
metastases in patient with endometrial cancer. Dis Markers.
2014:6803612014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li P, Wang J, Chu M, Zhang K, Yang R and
Gao WQ: Zeb1 promotes androgen independence of prostate cancer via
induction of stem cell-like properties. Exp Biol Med (Maywood).
239:813–822. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Quan Y, Jin R, Huang A, Zhao H, Feng B,
Zang L and Zheng M: Downregulation of GRHL2 inhibits the
proliferation of colorectal cancer cells by targeting ZEB1. Cancer
Biol Ther. 15:878–887. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sayan AE: Tumour-promoting role of
EMT-inducing transcription factor ZEB1 in mantle cell lymphoma.
Cell Death Differ. 21:194–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wellner U, Brabletz T and Keck T: ZEB1 in
pancreatic cancer. Cancers (Basel). 2:1617–1628. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hurt EM, Saykally JN, Anose BM, Kalli KR
and Sanders MM: Expression of the ZEB1 (deltaEF1) transcription
factor in human: Additional insights. Mol Cell Biochem. 318:89–99.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cho KR and Shih IeM: Ovarian cancer. Annu
Rev Pathol. 4:287–313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zivanovic O, Sima CS, Iasonos A, Hoskins
WJ, Pingle PR, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Barakat RR
and Chi DS: The effect of primary cytoreduction on outcomes of
patients with FIGO stage IIIC ovarian cancer stratified by the
initial tumor burden in the upper abdomen cephalad to the greater
omentum. Gynecol Oncol. 116:351–357. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang R, Ma Y, Holm R, Trope CG, Nesland
JM and Suo Z: Sex hormone-binding globulin (SHBG) expression in
ovarian carcinomas and its clinicopathological associations. PloS
one. 8:e832382013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang R, Wu D, Yuan Y, Li X, Holm R, Trope
CG, Nesland JM and Suo Z: CD117 expression in fibroblasts-like
stromal cells indicates unfavorable clinical outcomes in ovarian
carcinoma patients. PloS One. 9:e1122092014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sehouli J, Senyuva F, Fotopoulou C,
Neumann U, Denkert C, Werner L and Gülten OO: Intra-abdominal tumor
dissemination pattern and surgical outcome in 214 patients with
primary ovarian cancer. J Surg Oncol. 99:424–427. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harada K, Miyake H, Kusuda Y and Fujisawa
M: Expression of epithelial-mesenchymal transition markers in renal
cell carcinoma: Impact on prognostic outcomes in patients
undergoing radical nephrectomy. BJU Int. 110:E1131–E1137. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jia B, Liu H, Kong Q and Li B:
Overexpression of ZEB1 associated with metastasis and invasion in
patients with gastric carcinoma. Mol Cell Biochem. 366:223–229.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyahara S, Hamasaki M, Hamatake D,
Yamashita S, Shiraishi T, Iwasaki A and Nabeshima K:
Clinicopathological analysis of pleomorphic carcinoma of the lung:
Diffuse ZEB1 expression predicts poor survival. Lung Cancer.
87:39–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang X, Wang Q, Dai W, Zhang J and Chen X:
Overexpression of zinc finger E-box binding homeobox factor 1
promotes tumor invasiveness and confers unfavorable prognosis in
esophageal squamous cell carcinoma. Tumour Biol. 35:11977–11984.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Davidson B, Holth A, Hellesylt E, Tan TZ,
Huang RY, Tropé C, Nesland JM and Thiery JP: The clinical role of
epithelial-mesenchymal transition and stem cell markers in
advanced-stage ovarian serous carcinoma effusions. Hum Pathol.
46:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
